Wikidata

(Q44648834)

English

Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer.

scientific article published on 30 March 2009

In more languages

Statements

title
Phase III trial evaluating the addition of paclitaxel to doxorubicin followed by cyclophosphamide, methotrexate, and fluorouracil, as adjuvant or primary systemic therapy: European Cooperative Trial in Operable Breast Cancer (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
19332727
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19332727%20AND%20SRC:MED&resulttype=core&format=json
retrieved
25 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q44648834&oldid=1694330789"